The following words and terms when used in this chapter shall have the following meanings unless the context clearly indicates otherwise:
"Acute pain" means pain of any origin that has existed less than one month.
"Board" means the Virginia Board of Medicine.
"Chronic pain" means nonmalignant pain that goes beyond the normal course of a disease or condition for which controlled substances may be prescribed for a period greater than three months.
"Controlled substance" means drugs listed in The Drug Control Act (§ 54.1-3400 et seq. of the Code of Virginia) in Schedules II through IV.
"DMAS" means the Virginia Department of Medical Assistance Services.
"FDA" means the U.S. Food and Drug Administration.
"Induction phase" means the initial seven to 14 days of treatment with buprenorphine.
"MME" means morphine milligram equivalent.
"Prescription Monitoring Program" means the electronic system within the Department of Health Professions that monitors the dispensing of certain controlled substances.
"Subacute pain" means pain that has existed for one to three months.
18 Va. Admin. Code § 85-21-20
Statutory Authority: §§ 54.1-2400 and 54.1-2928.2 of the Code of Virginia.